Am J Transplant, Volume 18, Suppl 3 Archives - Page 105 of 211 - ATC Abstracts

2018 American Transplant Congress
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury
J. Wang, A. Nickkholgh, R. Shahbazov, S. Pelletier, D. Maluf.
Dept. of Surgery, University of Virginia Health System, Charlottesville, VA.
Background: Splenorenal shunt (SRS) is a type of portosystemic shunt that develops frequently in the setting of chronic portal hypertension and cirrhosis. It remains controversial…
2018 American Transplant Congress
Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy
B. Lee, Y. Choi, H. Han, Y. Yoon, J. Cho.
Department of Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
Background With the development of laparoscopic skills, its application has expanded in living donor liver transplantation. However, due to technical difficulties, pure laparoscopic donor hepatectomy…
2018 American Transplant Congress
Impact of Donor Age on Outcomes after Living Donor Liver Transplantation
K. Hayashi,¹ K. Gotoh,¹ H. Eguchi,¹ Y. Iwagami,¹ D. Yamada,¹ T. Asaoka,¹ T. Noda,¹ K. Kawamoto,¹ S. Kobayashi,¹ K. Umeshita,² Y. Doki,¹ M. Mori.¹
¹Dept of Gastroenterological Sugery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; ²Division of Health Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Background: Liver transplantation (LT) is a curative treatment for decompensated cirrhosis and fulminant hepatitis. Although not a few patients received LT with marginal donor livers…
2018 American Transplant Congress
Preventing Recurrence of Incisional Hernia after Liver Transplantation
J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Transplant Surgery, Indiana University, Indianapolis, IN.
Background: Incisional hernia is a well-known complication of orthotopic liver transplantation (OLT). Although factors that affect incidence of hernia after OLT have been described, recurrence…
2018 American Transplant Congress
A High Abdominal Aortic Calcification Score by Dual X-Ray Absorptiometry (DXA) is Associated with Cardiovascular Events after Kidney Transplantation
S. Benjamens,^1,2 R. A. Pol,¹ A. W. Glaudemans,² I. Wieringa,³ S. P. Berger,³ S. J. Bakker,³ R. H. Slart.²
¹Surgery, University Medical Center Groningen, Groningen, Netherlands; ²Medical Imaging Center, UMCG, Groningen, Netherlands; ³Nephrology, UMCG, Groningen, Netherlands.
Introduction: It is unknown whether aortic calcification is associated with increased risk for cardiovascular events in renal transplant recipients. Therefore, this study focused on the…
2018 American Transplant Congress
Effect of Belatacept on Late Acute Rejection Episodes and Graft Loss in Young Adults between the Ages of 18-24 Years: Post-Hoc Analysis of BENEFIT Study
A. Moudgil.
Nephrology, Children National Health System, Washington, DC.
Background: Recent data suggests higher incidence of late acute rejection (LAR) in young adults (18-24 years of age) causing graft loss just like adolescents due…
2018 American Transplant Congress
Superiority of Early Everolimus-Based Quadruple Immunosuppression versus Standard Triple Therapy after Lung Transplantation: 12 Months Results from Prospective 4EVERLUNG Study in Germany
J. Gottlieb, C. Neurohr, J. Müller-Quernheim, H. Wirtz, B. Sill, H. Wilkens, V. Besa, C. Knosalla, M. Junge, C. Capusan, M. Strüber.
Klinik, Hannover, Germany; Klinik, München, Germany; Klinik, Freiburg, Germany; Klinik, Leipzig, Germany; Klinik, Hamburg, Germany; Klinik, Homburg, Germany; Klinik, Essen, Germany; Klinik, Berlin, Germany; Novartis Pharma, Nürnberg, Germany; Novartis Pharma, Nürnberg, Germany; Klinik, Hannover, Germany.
The 4Everlung trial was designed to evaluate the benefit of early everolimus (EVR)-based quadruple low immunosuppressive (IS) regimen on kidney function (RF) after LTx.4EVERLUNG is…
2018 American Transplant Congress
Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection
C. Lefaucheur,¹ D. Viglietti,¹ O. Aubert,¹ A. Philippe,² P. Halloran,³ A. Loupy,¹ D. Dragun.²
¹Paris Translational Research Center for Organ Transplantation, Paris, France; ²Medical Faculty of the Charité, Berlin, Germany; ³Alberta Transplant Applied Genomics Centre, Edmonton, Canada.
AT1R-Ab have been associated with kidney allograft rejection; however, their ability to induce a specific rejection phenotype, independent of HLA-DSAs, has not been defined.In a…
2018 American Transplant Congress
Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies
F. Shihab,¹ Y. Qazi,^1,2 V. Peddi,¹ D. Shaffer,¹ D. Kim,^1,2 K. McCague,³ D. Patel,³ S. Mulgaonkar.^1,2
¹US92 Study Group, Salt Lake City; ²TRANSFORM Study Group, East Hanover; ³Novartis Pharmaceuticals Corporation, East Hanover.
Purpose: Attainment of everolimus (EVR) target trough level (C0 3-8ng/mL) is crucial in achieving comparable efficacy-safety with EVR+reduced (r) calcineurin inhibitor regimen (CNI; tacrolimus [TAC]…
2018 American Transplant Congress
Estimated GFR at Donor Screening and Achieved Measured GFR after Living Kidney Donation
M. van Londen, J. van der Weijden, S. Bakker, S. Berger, J. Sanders, G. Navis, M. de Borst.
Internal Medicine, Division of Nephrology, University Medical Center Groningen, Groningen, Netherlands.
Study Purpose: Accurate pre-donation renal function estimation is important to minimize the risk of future severe renal function impairment in living kidney donors. Recent studies…